{
    "abstract": "Background: Native American populations experience a substantial burden of pneumococcal disease despite use of highly effective pneumococcal conjugate vaccines (PCVs). Protein-based pneumococcal vaccines may extend protection beyond the serotype-specific protection elicited by PCVs. Methods: In this phase IIb, double-blind, controlled trial, 6\u201312 weeks-old Native American infants randomized 1:1, received either a protein-based pneumococcal vaccine (dPly/PhtD) containing pneumolysin toxoid (dPly, 10 \u00b5g) and pneumococcal histidine triad protein D (PhtD, 10 \u00b5g) or placebo, administered along with 13-valent PCV (PCV13) at ages 2, 4, 6 and 12\u201315 months. Other pediatric vaccines were given per the routine immunization schedule. We assessed vaccine efficacy (VE) against acute otitis media (AOM) and acute lower respiratory tract infection (ALRI) endpoints. Immunogenicity, reactogenicity and unsolicited adverse events were assessed in a sub-cohort and serious adverse events were assessed in all children. Results: 1803 infants were randomized (900 dPly/PhtD; 903 Control). VE against all episodes of American Academy of Pediatrics (AAP)-defined AOM was 3.8% (95% confidence interval: \u221211.4, 16.9). Point estimates of VE against other AOM outcomes ranged between 2.9% (\u22129.5, 14.0) and 5.2% (\u22128.0, 16.8). Point estimates of VE against ALRI outcomes ranged between \u22124.4% (\u221239.2, 21.8) and 2.0% (\u221218.3, 18.8). Point estimates of VE tended to be higher against first than all episodes but the confidence intervals included zero. dPly/PhtD vaccine was immunogenic and had an acceptable reactogenicity and safety profile after primary and booster vaccination in Native American infants. Conclusions: The dPly/PhtD vaccine was immunogenic and well tolerated, however, incremental efficacy in preventing AAP-AOM over PCV13 was not demonstrated. Clinical trials registration: NCT01545375 (www.clinicaltrials.gov)",
    "author_highlights": [
        {
            "endOffset": 17568,
            "sentence": "Protein antigens could offer serotype-independent protection against pneumococcal infection.",
            "startOffset": 17476
        },
        {
            "endOffset": 17659,
            "sentence": "dPly/PhtD was assessed in healthy Native American infants when co-administered with PCV13.",
            "startOffset": 17569
        },
        {
            "endOffset": 17712,
            "sentence": "Vaccine efficacy against AOM and ALRI was evaluated.",
            "startOffset": 17660
        },
        {
            "endOffset": 17808,
            "sentence": "dPly/PhtD was immunogenic but incremental efficacy against AOM over PCV13 was not demonstrated.",
            "startOffset": 17713
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Wahl"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Adena",
                    "initial": "A.",
                    "last": "Greenbaum"
                },
                {
                    "first": "Anwesha",
                    "initial": "A.",
                    "last": "Majumder"
                },
                {
                    "first": "Li",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "Yue",
                    "initial": "Y.",
                    "last": "Chu"
                },
                {
                    "first": "Ivana",
                    "initial": "I.",
                    "last": "Luk\u0161i\u0107"
                },
                {
                    "first": "Harish",
                    "initial": "H.",
                    "last": "Nair"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "McAllister"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Rudan"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Black"
                },
                {
                    "first": "Maria Deloria",
                    "initial": "M.D.",
                    "last": "Knoll"
                }
            ],
            "doi": "10.1016/S2214-109X(18)30247-X",
            "firstpage": "e744",
            "issn": "2214109X",
            "lastpage": "e757",
            "pmid": "29903376",
            "pub_year": 2018,
            "title": "Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315",
            "volume": "6"
        },
        "b0010": null,
        "b0015": {
            "authors": [
                {
                    "first": "Margaret Mary",
                    "initial": "M.M.",
                    "last": "Cortese"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Wolff"
                },
                {
                    "first": "Jann\u00e9",
                    "initial": "J.",
                    "last": "Almeido Hill"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Reid"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Ketcham"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                }
            ],
            "doi": "10.1001/archinte.1992.00400230087015",
            "firstpage": "2277",
            "issn": "00039926",
            "lastpage": "2282",
            "pmid": "1444688",
            "pub_year": 1992,
            "title": "High Incidence Rates of Invasive Pneumococcal Disease in the White Mountain Apache Population",
            "volume": "152"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Davidson"
                },
                {
                    "first": "Alan J.",
                    "initial": "A.J.",
                    "last": "Parkinson"
                },
                {
                    "first": "Lisa R.",
                    "initial": "L.R.",
                    "last": "Bulkow"
                },
                {
                    "first": "Mary Anne",
                    "initial": "M.A.",
                    "last": "Fitzgerald"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Peters"
                },
                {
                    "first": "Debra J.",
                    "initial": "D.J.",
                    "last": "Parks"
                }
            ],
            "doi": "10.1093/infdis/170.2.368",
            "firstpage": "368",
            "issn": "00221899",
            "lastpage": "376",
            "pmid": "8035023",
            "pub_year": 1994,
            "title": "The epidemiology of invasive pneumococcal disease in alaska, 1986-1990 ethnic differences and opportunities for prevention",
            "volume": "170"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                }
            ],
            "doi": "10.1093/aje/kwh082",
            "firstpage": "634",
            "issn": "00029262",
            "lastpage": "644",
            "pmid": "15033641",
            "pub_year": 2004,
            "title": "Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases",
            "volume": "159"
        },
        "b0030": {
            "authors": [
                {
                    "first": "James P.",
                    "initial": "J.P.",
                    "last": "Watt"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Andrea L.",
                    "initial": "A.L.",
                    "last": "Benin"
                },
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Robinson"
                },
                {
                    "first": "Alan J.",
                    "initial": "A.J.",
                    "last": "Parkinson"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Reid"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                }
            ],
            "doi": "10.1086/381198",
            "firstpage": "496",
            "issn": "10584838",
            "lastpage": "501",
            "pmid": "14765341",
            "pub_year": 2004,
            "title": "Invasive Pneumococcal Disease among Navajo Adults, 1989-1998",
            "volume": "38"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Michael G.",
                    "initial": "M.G.",
                    "last": "Bruce"
                },
                {
                    "first": "Rosalyn",
                    "initial": "R.",
                    "last": "Singleton"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Bulkow"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Rudolph"
                },
                {
                    "first": "Tammy",
                    "initial": "T.",
                    "last": "Zulz"
                },
                {
                    "first": "Prabhu",
                    "initial": "P.",
                    "last": "Gounder"
                },
                {
                    "first": "Debby",
                    "initial": "D.",
                    "last": "Hurlburt"
                },
                {
                    "first": "Dana",
                    "initial": "D.",
                    "last": "Bruden"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Hennessy"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.07.080",
            "firstpage": "4813",
            "issn": "0264410X",
            "lastpage": "4819",
            "pmid": "26247901",
            "pub_year": 2015,
            "title": "Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska",
            "volume": "33"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Weatherholtz"
                },
                {
                    "first": "Eugene V.",
                    "initial": "E.V.",
                    "last": "Millar"
                },
                {
                    "first": "Lawrence H.",
                    "initial": "L.H.",
                    "last": "Moulton"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Reid"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Rudolph"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                }
            ],
            "doi": "10.1086/651680",
            "firstpage": "1238",
            "issn": "10584838",
            "lastpage": "1246",
            "pmid": "20367225",
            "pub_year": 2010,
            "title": "Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an american indian population at high risk for disease",
            "volume": "50"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Mark R.",
                    "initial": "M.R.",
                    "last": "Alderson"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.03.107",
            "firstpage": "2959",
            "issn": "0264410X",
            "lastpage": "2961",
            "pmid": "27083428",
            "pub_year": 2016,
            "title": "Status of research and development of pediatric vaccines for Streptococcus pneumoniae",
            "volume": "34"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Bart A.",
                    "initial": "B.A.",
                    "last": "Eijkelkamp"
                },
                {
                    "first": "Victoria G.",
                    "initial": "V.G.",
                    "last": "Pederick"
                },
                {
                    "first": "Charles D.",
                    "initial": "C.D.",
                    "last": "Plumptre"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Harvey"
                },
                {
                    "first": "Catherine E.",
                    "initial": "C.E.",
                    "last": "Hughes"
                },
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Paton"
                },
                {
                    "first": "Christopher A.",
                    "initial": "C.A.",
                    "last": "McDevitt"
                }
            ],
            "doi": "10.1128/IAI.01082-15",
            "firstpage": "407",
            "issn": "00199567",
            "lastpage": "415",
            "pmid": "26573735",
            "pub_year": 2016,
            "title": "The first histidine triad motif of PhtD is critical for zinc homeostasis in Streptococcus pneumoniae",
            "volume": "84"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Hermand"
                },
                {
                    "first": "Annick",
                    "initial": "A.",
                    "last": "Vandercammen"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Mertens"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Di Paolo"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Deno\u00ebl"
                },
                {
                    "first": "Fabrice",
                    "initial": "F.",
                    "last": "Godfroid"
                }
            ],
            "doi": "10.1080/21645515.2016.1234553",
            "firstpage": "220",
            "issn": "21645515",
            "lastpage": "228",
            "pmid": "27768518",
            "pub_year": 2017,
            "title": "Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen",
            "volume": "13"
        },
        "b0065": {
            "authors": [
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Rioux"
                },
                {
                    "first": "C\u00e9cile",
                    "initial": "C.",
                    "last": "Neyt"
                },
                {
                    "first": "Emmanuel",
                    "initial": "E.",
                    "last": "Di Paolo"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Turpin"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Charland"
                },
                {
                    "first": "Steve",
                    "initial": "S.",
                    "last": "Labb\u00e9"
                },
                {
                    "first": "Marie C\u00e9cile",
                    "initial": "M.C.",
                    "last": "Mortier"
                },
                {
                    "first": "Tim J.",
                    "initial": "T.J.",
                    "last": "Mitchell"
                },
                {
                    "first": "Christiane",
                    "initial": "C.",
                    "last": "Feron"
                },
                {
                    "first": "Denis",
                    "initial": "D.",
                    "last": "Martin"
                },
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                }
            ],
            "doi": "10.1099/mic.0.042184-0",
            "firstpage": "335",
            "issn": "13500872",
            "lastpage": "348",
            "pmid": "20966093",
            "pub_year": 2011,
            "title": "Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae",
            "volume": "157"
        },
        "b0070": {
            "authors": [
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Adamou"
                },
                {
                    "first": "J. H.",
                    "initial": "J.H.",
                    "last": "Heinrichs"
                },
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Erwin"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Walsh"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Gayle"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dormitzer"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Dagan"
                },
                {
                    "first": "Y. A.",
                    "initial": "Y.A.",
                    "last": "Brewah"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Barren"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Lathigra"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Langermann"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Koenig"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Johnson"
                }
            ],
            "doi": "10.1128/IAI.69.2.949-958.2001",
            "firstpage": "949",
            "issn": "00199567",
            "lastpage": "958",
            "pmid": "11159990",
            "pub_year": 2001,
            "title": "Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis",
            "volume": "69"
        },
        "b0075": {
            "authors": [
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Alexander"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Lock"
                },
                {
                    "first": "C. C.A.M.",
                    "initial": "C.C.A.M.",
                    "last": "Peeters"
                },
                {
                    "first": "J. T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                },
                {
                    "first": "P. W.",
                    "initial": "P.W.",
                    "last": "Andrew"
                },
                {
                    "first": "T. J.",
                    "initial": "T.J.",
                    "last": "Mitchell"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Hansman"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Paton"
                }
            ],
            "firstpage": "5683",
            "issn": "00199567",
            "lastpage": "5688",
            "pmid": "7960154",
            "pub_year": 1994,
            "title": "Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae",
            "volume": "62"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Deno\u00ebl"
                },
                {
                    "first": "Fabrice",
                    "initial": "F.",
                    "last": "Godfroid"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Hermand"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.01.085",
            "firstpage": "6451",
            "issn": "0264410X",
            "lastpage": "6453",
            "pmid": "21315695",
            "pub_year": 2011,
            "title": "Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides",
            "volume": "29"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Deno\u00ebl"
                },
                {
                    "first": "Mario T.",
                    "initial": "M.T.",
                    "last": "Philipp"
                },
                {
                    "first": "Lara",
                    "initial": "L.",
                    "last": "Doyle"
                },
                {
                    "first": "Dale",
                    "initial": "D.",
                    "last": "Martin"
                },
                {
                    "first": "Georges",
                    "initial": "G.",
                    "last": "Carletti"
                },
                {
                    "first": "Jan T.",
                    "initial": "J.T.",
                    "last": "Poolman"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.05.051",
            "firstpage": "5495",
            "issn": "0264410X",
            "lastpage": "5501",
            "pmid": "21624422",
            "pub_year": 2011,
            "title": "A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae",
            "volume": "29"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Ravinder",
                    "initial": "R.",
                    "last": "Kaur"
                },
                {
                    "first": "Naveen",
                    "initial": "N.",
                    "last": "Surendran"
                },
                {
                    "first": "Martina",
                    "initial": "M.",
                    "last": "Ochs"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                }
            ],
            "doi": "10.1128/IAI.02124-14",
            "firstpage": "5069",
            "issn": "00199567",
            "lastpage": "5075",
            "pmid": "25245804",
            "pub_year": 2014,
            "title": "Human antibodies to PhtD, PcpA, and ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae",
            "volume": "82"
        },
        "b0095": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Odutola"
                },
                {
                    "first": "M. O.",
                    "initial": "M.O.",
                    "last": "Ota"
                },
                {
                    "first": "E. O.",
                    "initial": "E.O.",
                    "last": "Ogundare"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Owiafe"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Worwui"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Greenwood"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Alderson"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Dobbelaere"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1080/21645515.2015.1111496",
            "firstpage": "393",
            "issn": "21645515",
            "lastpage": "402",
            "pmid": "26618243",
            "pub_year": 2016,
            "title": "Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2\u20134\u00a0years: A phase II randomized study",
            "volume": "12"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Aderonke",
                    "initial": "A.",
                    "last": "Odutola"
                },
                {
                    "first": "Martin O.C.",
                    "initial": "M.O.C.",
                    "last": "Ota"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Ezra O.",
                    "initial": "E.O.",
                    "last": "Ogundare"
                },
                {
                    "first": "Yauba",
                    "initial": "Y.",
                    "last": "Saidu"
                },
                {
                    "first": "Ebenezer",
                    "initial": "E.",
                    "last": "Foster-Nyarko"
                },
                {
                    "first": "Patrick K.",
                    "initial": "P.K.",
                    "last": "Owiafe"
                },
                {
                    "first": "Fatima",
                    "initial": "F.",
                    "last": "Ceesay"
                },
                {
                    "first": "Archibald",
                    "initial": "A.",
                    "last": "Worwui"
                },
                {
                    "first": "Olubukola T.",
                    "initial": "O.T.",
                    "last": "Idoko"
                },
                {
                    "first": "Olumuyiwa",
                    "initial": "O.",
                    "last": "Owolabi"
                },
                {
                    "first": "Abdoulie",
                    "initial": "A.",
                    "last": "Bojang"
                },
                {
                    "first": "Sheikh",
                    "initial": "S.",
                    "last": "Jarju"
                },
                {
                    "first": "Isatou",
                    "initial": "I.",
                    "last": "Drammeh"
                },
                {
                    "first": "Beate",
                    "initial": "B.",
                    "last": "Kampmann"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Alderson"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Devos"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Schoonbroodt"
                },
                {
                    "first": "Kristien",
                    "initial": "K.",
                    "last": "Swinnen"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Kurt",
                    "initial": "K.",
                    "last": "Dobbelaere"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.03.071",
            "firstpage": "2531",
            "issn": "0264410X",
            "lastpage": "2542",
            "pmid": "28389097",
            "pub_year": 2017,
            "title": "Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study",
            "volume": "35"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Petr",
                    "initial": "P.",
                    "last": "Pazdiora"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "Jens U.",
                    "initial": "J.U.",
                    "last": "R\u00fcggeberg"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.03.066",
            "firstpage": "3025",
            "issn": "0264410X",
            "lastpage": "3034",
            "pmid": "24699466",
            "pub_year": 2014,
            "title": "Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial",
            "volume": "32"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Leszek",
                    "initial": "L.",
                    "last": "Szenborn"
                },
                {
                    "first": "Sven Arne",
                    "initial": "S.A.",
                    "last": "Silfverdal"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Wysocki"
                },
                {
                    "first": "Piotr",
                    "initial": "P.",
                    "last": "Albrecht"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "Asparuh",
                    "initial": "A.",
                    "last": "Gardev"
                },
                {
                    "first": "Yue",
                    "initial": "Y.",
                    "last": "Song"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.07.008",
            "firstpage": "4603",
            "issn": "0264410X",
            "lastpage": "4611",
            "pmid": "28729019",
            "pub_year": 2017,
            "title": "Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants",
            "volume": "35"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Grohskopf"
                },
                {
                    "first": "Timothy",
                    "initial": "T.",
                    "last": "Uyeki"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Bresee"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Cox"
                },
                {
                    "first": "Carolyn",
                    "initial": "C.",
                    "last": "Bridges"
                }
            ],
            "firstpage": "1128",
            "issn": "01492195",
            "lastpage": "1132",
            "pmid": "21866086",
            "pub_year": 2011,
            "title": "Prevention and control of influenza with vaccines: Recommendations of the advisory committee on immunization practices (ACIP), 2011",
            "volume": "60"
        },
        "b0120": {
            "authors": [],
            "doi": "10.1542/peds.113.5.1451",
            "firstpage": "1451",
            "issn": "00314005",
            "lastpage": "1465",
            "pmid": "15121972",
            "pub_year": 2004,
            "title": "Diagnosis and Management of Acute Otitis Media",
            "volume": "113"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Cathy",
                    "initial": "C.",
                    "last": "Maes"
                },
                {
                    "first": "Fien",
                    "initial": "F.",
                    "last": "De Boever"
                },
                {
                    "first": "Magali",
                    "initial": "M.",
                    "last": "Traskine"
                },
                {
                    "first": "Jens U.",
                    "initial": "J.U.",
                    "last": "R\u00fcggeberg"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.02.052",
            "firstpage": "6838",
            "issn": "0264410X",
            "lastpage": "6846",
            "pmid": "24607003",
            "pub_year": 2014,
            "title": "Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study",
            "volume": "32"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Prymula"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Peeters"
                },
                {
                    "first": "Viktor",
                    "initial": "V.",
                    "last": "Chrobok"
                },
                {
                    "first": "Pavla",
                    "initial": "P.",
                    "last": "Kriz"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Novakova"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Kaliskova"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Kohl"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Jean Paul",
                    "initial": "J.P.",
                    "last": "Prieels"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1016/S0140-6736(06)68304-9",
            "firstpage": "740",
            "issn": "01406736",
            "lastpage": "748",
            "pmid": "16517274",
            "pub_year": 2006,
            "title": "Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised double-blind efficacy study",
            "volume": "367"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Melissa K.",
                    "initial": "M.K.",
                    "last": "Van Dyke"
                },
                {
                    "first": "Jean Yves",
                    "initial": "J.Y.",
                    "last": "Pir\u00e7on"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Cohen"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Andr\u00e9s",
                    "initial": "A.",
                    "last": "Rosenbl\u00fct"
                },
                {
                    "first": "Mercedes Macias",
                    "initial": "M.M.",
                    "last": "Parra"
                },
                {
                    "first": "Khalid",
                    "initial": "K.",
                    "last": "Al-Mazrou"
                },
                {
                    "first": "Gerhard",
                    "initial": "G.",
                    "last": "Grevers"
                },
                {
                    "first": "Pio",
                    "initial": "P.",
                    "last": "Lopez"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Naranjo"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Pumarola"
                },
                {
                    "first": "Nuntigar",
                    "initial": "N.",
                    "last": "Sonsuwan"
                },
                {
                    "first": "William P.",
                    "initial": "W.P.",
                    "last": "Hausdorff"
                }
            ],
            "doi": "10.1097/INF.0000000000001420",
            "firstpage": "274",
            "issn": "08913668",
            "lastpage": "281",
            "pmid": "27918383",
            "pub_year": 2017,
            "title": "Etiology of acute otitis media in children less than 5 years of age: A pooled analysis of 10 similarly designed observational studies",
            "volume": "36"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Janet R.",
                    "initial": "J.R.",
                    "last": "Casey"
                },
                {
                    "first": "Diana G.",
                    "initial": "D.G.",
                    "last": "Adlowitz"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                }
            ],
            "doi": "10.1097/INF.0b013e3181c1bc48",
            "firstpage": "304",
            "issn": "08913668",
            "lastpage": "309",
            "pub_year": 2010,
            "title": "New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine",
            "volume": "29"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Juhani",
                    "initial": "J.",
                    "last": "Eskola"
                },
                {
                    "first": "Terhi",
                    "initial": "T.",
                    "last": "Kilpi"
                },
                {
                    "first": "Arto",
                    "initial": "A.",
                    "last": "Palmu"
                },
                {
                    "first": "Jukka",
                    "initial": "J.",
                    "last": "Jokinen"
                },
                {
                    "first": "Jaason",
                    "initial": "J.",
                    "last": "Haapakoski"
                },
                {
                    "first": "Elja",
                    "initial": "E.",
                    "last": "Herva"
                },
                {
                    "first": "Aino",
                    "initial": "A.",
                    "last": "Takala"
                },
                {
                    "first": "Helena",
                    "initial": "H.",
                    "last": "K\u00e4yhty"
                },
                {
                    "first": "Pekka",
                    "initial": "P.",
                    "last": "Karma"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Kohberger"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Siber"
                },
                {
                    "first": "P. Helena",
                    "initial": "P.H.",
                    "last": "M\u00e4kel\u00e4"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Lockhart"
                },
                {
                    "first": "Mervi",
                    "initial": "M.",
                    "last": "Eerola"
                }
            ],
            "doi": "10.1056/NEJM200102083440602",
            "firstpage": "403",
            "issn": "00284793",
            "lastpage": "409",
            "pmid": "11172176",
            "pub_year": 2001,
            "title": "Efficacy of a pneumococcal conjugate vaccine against acute otitis media",
            "volume": "344"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Angeline B.",
                    "initial": "A.B.",
                    "last": "David"
                },
                {
                    "first": "Aruna",
                    "initial": "A.",
                    "last": "Chandran"
                },
                {
                    "first": "Lawrence H.",
                    "initial": "L.H.",
                    "last": "Moulton"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Reid"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Weatherholtz"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                }
            ],
            "doi": "10.1097/INF.0b013e318159228f",
            "firstpage": "71",
            "issn": "08913668",
            "lastpage": "73",
            "pmid": "18162944",
            "pub_year": 2008,
            "title": "Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among navajo and white mountain apache infants",
            "volume": "27"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Miguel W.",
                    "initial": "M.W.",
                    "last": "Tregnaghi"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "S\u00e1ez-Llorens"
                },
                {
                    "first": "Pio",
                    "initial": "P.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Hector",
                    "initial": "H.",
                    "last": "Abate"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Smith"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "P\u00f3sleman"
                },
                {
                    "first": "Arlene",
                    "initial": "A.",
                    "last": "Calvo"
                },
                {
                    "first": "Digna",
                    "initial": "D.",
                    "last": "Wong"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Cortes-Barbosa"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Ceballos"
                },
                {
                    "first": "Marcelo",
                    "initial": "M.",
                    "last": "Tregnaghi"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Sierra"
                },
                {
                    "first": "Mirna",
                    "initial": "M.",
                    "last": "Rodriguez"
                },
                {
                    "first": "Marisol",
                    "initial": "M.",
                    "last": "Troiti\u00f1o"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Carabajal"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Falaschi"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Leandro"
                },
                {
                    "first": "Maria Mercedes",
                    "initial": "M.M.",
                    "last": "Castrej\u00f3n"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Lepetic"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Lommel"
                },
                {
                    "first": "William P.",
                    "initial": "W.P.",
                    "last": "Hausdorff"
                },
                {
                    "first": "Dorota",
                    "initial": "D.",
                    "last": "Borys"
                },
                {
                    "first": "Javier Ruiz",
                    "initial": "J.R.",
                    "last": "Gui\u00f1az\u00fa"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Ortega-Barr\u00eda"
                },
                {
                    "first": "Juan P.",
                    "initial": "J.P.",
                    "last": "Yarz\u00e1bal"
                },
                {
                    "first": "Lode",
                    "initial": "L.",
                    "last": "Schuerman"
                }
            ],
            "doi": "10.1371/journal.pmed.1001657",
            "firstpage": "1",
            "issn": "15491277",
            "lastpage": "18",
            "pmid": "24892763",
            "pub_year": 2014,
            "title": "Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial",
            "volume": "11"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Kelly"
                },
                {
                    "first": "Lynette L.Y.",
                    "initial": "L.L.Y.",
                    "last": "Lim"
                }
            ],
            "doi": "10.1002/(SICI)1097-0258(20000115)19:1<13::AID-SIM279>3.0.CO;2-5",
            "firstpage": "13",
            "issn": "02776715",
            "lastpage": "33",
            "pmid": "10623910",
            "pub_year": 2000,
            "title": "Survival analysis for recurrent event data: An application to childhood infectious diseases",
            "volume": "19"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.07.085",
            "firstpage": "6469",
            "issn": "0264410X",
            "lastpage": "6472",
            "pmid": "26256526",
            "pub_year": 2015,
            "title": "Maternal antibodies and infant immune responses to vaccines",
            "volume": "33"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Brendan",
                    "initial": "B.",
                    "last": "Flannery"
                },
                {
                    "first": "Jessie R.",
                    "initial": "J.R.",
                    "last": "Chung"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Huong Q.",
                    "initial": "H.Q.",
                    "last": "McLean"
                },
                {
                    "first": "Manjusha",
                    "initial": "M.",
                    "last": "Gaglani"
                },
                {
                    "first": "Kempapura",
                    "initial": "K.",
                    "last": "Murthy"
                },
                {
                    "first": "Richard K.",
                    "initial": "R.K.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Mary Patricia",
                    "initial": "M.P.",
                    "last": "Nowalk"
                },
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Jackson"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Jackson"
                },
                {
                    "first": "Arnold S.",
                    "initial": "A.S.",
                    "last": "Monto"
                },
                {
                    "first": "Emily T.",
                    "initial": "E.T.",
                    "last": "Martin"
                },
                {
                    "first": "Angie",
                    "initial": "A.",
                    "last": "Foust"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Sessions"
                },
                {
                    "first": "La Shondra",
                    "initial": "L.S.",
                    "last": "Berman"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Barnes"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Spencer"
                },
                {
                    "first": "Alicia M.",
                    "initial": "A.M.",
                    "last": "Fry"
                }
            ],
            "doi": "10.15585/mmwr.mm6706a2",
            "firstpage": "180",
            "issn": "01492195",
            "lastpage": "185",
            "pmid": "29447141",
            "pub_year": 2018,
            "title": "Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018",
            "volume": "67"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Mohd N.",
                    "initial": "M.N.",
                    "last": "Norhayati"
                },
                {
                    "first": "Jacqueline J.",
                    "initial": "J.J.",
                    "last": "Ho"
                },
                {
                    "first": "Mohd Y.",
                    "initial": "M.Y.",
                    "last": "Azman"
                }
            ],
            "doi": "10.1002/14651858.CD010089.pub2",
            "issn": "1469493X",
            "pmid": "25803008",
            "pub_year": 2015,
            "title": "Influenza vaccines for preventing acute otitis media in infants and children",
            "volume": "2015"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Salha"
                },
                {
                    "first": "Jason",
                    "initial": "J.",
                    "last": "Szeto"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Myers"
                },
                {
                    "first": "Carol",
                    "initial": "C.",
                    "last": "Claus"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Sheung"
                },
                {
                    "first": "Mei",
                    "initial": "M.",
                    "last": "Tang"
                },
                {
                    "first": "Belma",
                    "initial": "B.",
                    "last": "Ljutic"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Hanwell"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Ogilvie"
                },
                {
                    "first": "Marin",
                    "initial": "M.",
                    "last": "Ming"
                },
                {
                    "first": "Benjamin",
                    "initial": "B.",
                    "last": "Messham"
                },
                {
                    "first": "Germie",
                    "initial": "G.",
                    "last": "van den Dobbelsteen"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Hopfer"
                },
                {
                    "first": "Martina M.",
                    "initial": "M.M.",
                    "last": "Ochs"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Gallichan"
                }
            ],
            "doi": "10.1128/IAI.06348-11",
            "firstpage": "2212",
            "issn": "00199567",
            "lastpage": "2220",
            "pmid": "22473606",
            "pub_year": 2012,
            "title": "Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury",
            "volume": "80"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Lindsay R.",
                    "initial": "L.R.",
                    "last": "Grant"
                },
                {
                    "first": "Laura L.",
                    "initial": "L.L.",
                    "last": "Hammitt"
                },
                {
                    "first": "Sarah E.",
                    "initial": "S.E.",
                    "last": "O'Brien"
                },
                {
                    "first": "Michael R.",
                    "initial": "M.R.",
                    "last": "Jacobs"
                },
                {
                    "first": "Connie",
                    "initial": "C.",
                    "last": "Donaldson"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Weatherholtz"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Reid"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                }
            ],
            "doi": "10.1097/INF.0000000000001207",
            "firstpage": "907",
            "issn": "08913668",
            "lastpage": "914",
            "pmid": "27171679",
            "pub_year": 2016,
            "title": "Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage among American Indians",
            "volume": "35"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Awa L.",
                    "initial": "A.L.",
                    "last": "Mendy"
                },
                {
                    "first": "Schadrac C.",
                    "initial": "S.C.",
                    "last": "Agbla"
                },
                {
                    "first": "Aderonke A.",
                    "initial": "A.A.",
                    "last": "Odutola"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Antonio"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Greenwood"
                },
                {
                    "first": "Jayne S.",
                    "initial": "J.S.",
                    "last": "Sutherland"
                },
                {
                    "first": "Martin O.C.",
                    "initial": "M.O.C.",
                    "last": "Ota"
                }
            ],
            "doi": "10.1371/journal.pone.0185824",
            "issn": "19326203",
            "pmid": "28982123",
            "pub_year": 2017,
            "title": "Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life",
            "volume": "12"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Q.",
                    "initial": "Q.",
                    "last": "Xu"
                },
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "Casey"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Almudevar"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                }
            ],
            "doi": "10.1016/j.cmi.2017.01.011",
            "firstpage": "487",
            "issn": "1198743X",
            "lastpage": "487.e6",
            "pmid": "28143785",
            "pub_year": 2017,
            "title": "Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children",
            "volume": "23"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Qingfu",
                    "initial": "Q.",
                    "last": "Xu"
                },
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Pryharski"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.11.046",
            "firstpage": "337",
            "issn": "0264410X",
            "lastpage": "344",
            "pmid": "27919628",
            "pub_year": 2017,
            "title": "Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model",
            "volume": "35"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Alexandre C.",
                    "initial": "A.C.",
                    "last": "Fortanier"
                },
                {
                    "first": "Roderick P.",
                    "initial": "R.P.",
                    "last": "Venekamp"
                },
                {
                    "first": "Chantal Wb",
                    "initial": "C.W.",
                    "last": "Boonacker"
                },
                {
                    "first": "Eelko",
                    "initial": "E.",
                    "last": "Hak"
                },
                {
                    "first": "Anne Gm",
                    "initial": "A.G.",
                    "last": "Schilder"
                },
                {
                    "first": "Elisabeth Am",
                    "initial": "E.A.",
                    "last": "Sanders"
                },
                {
                    "first": "Roger Amj",
                    "initial": "R.A.",
                    "last": "Damoiseaux"
                }
            ],
            "doi": "10.1002/14651858.CD001480.pub5",
            "firstpage": "CD001480",
            "issn": "1469493X",
            "pmid": "31135969",
            "pub_year": 2019,
            "title": "Pneumococcal conjugate vaccines for preventing acute otitis media in children",
            "volume": "5"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Ravinder",
                    "initial": "R.",
                    "last": "Kaur"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Morris"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                }
            ],
            "doi": "10.1542/peds.2017-0181",
            "issn": "00314005",
            "pmid": "28784702",
            "pub_year": 2017,
            "title": "Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era",
            "volume": "140"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Corinne",
                    "initial": "C.",
                    "last": "Levy"
                },
                {
                    "first": "Emmanuelle",
                    "initial": "E.",
                    "last": "Varon"
                },
                {
                    "first": "Naim",
                    "initial": "N.",
                    "last": "Ouldali"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Wollner"
                },
                {
                    "first": "Franck",
                    "initial": "F.",
                    "last": "Thollot"
                },
                {
                    "first": "Fran\u00e7ois",
                    "initial": "F.",
                    "last": "Corrard"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Werner"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "B\u00e9chet"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Bonacorsi"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Cohen"
                }
            ],
            "doi": "10.1371/journal.pone.0211712",
            "issn": "19326203",
            "pmid": "30707730",
            "pub_year": 2019,
            "title": "Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine",
            "volume": "14"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Phillip H.",
                    "initial": "P.H.",
                    "last": "Kaleida"
                },
                {
                    "first": "Dianna L.",
                    "initial": "D.L.",
                    "last": "Ploof"
                },
                {
                    "first": "Marcia",
                    "initial": "M.",
                    "last": "Kurs-Lasky"
                },
                {
                    "first": "Nader",
                    "initial": "N.",
                    "last": "Shaikh"
                },
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Colborn"
                },
                {
                    "first": "Mary Ann",
                    "initial": "M.A.",
                    "last": "Haralam"
                },
                {
                    "first": "Sean",
                    "initial": "S.",
                    "last": "Ray"
                },
                {
                    "first": "Diana",
                    "initial": "D.",
                    "last": "Kearney"
                },
                {
                    "first": "Jack L.",
                    "initial": "J.L.",
                    "last": "Paradise"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Hoberman"
                }
            ],
            "doi": "10.1542/peds.2008-2838",
            "firstpage": "e714",
            "issn": "00314005",
            "lastpage": "e720",
            "pmid": "19786431",
            "pub_year": 2009,
            "title": "Mastering diagnostic skills: Enhancing proficiency in otitis media, a model for diagnostic skills training",
            "volume": "124"
        },
        "b0225": {
            "authors": [
                {
                    "first": "Allan S.",
                    "initial": "A.S.",
                    "last": "Lieberthal"
                },
                {
                    "first": "Aaron E.",
                    "initial": "A.E.",
                    "last": "Carroll"
                },
                {
                    "first": "Tasnee",
                    "initial": "T.",
                    "last": "Chonmaitree"
                },
                {
                    "first": "Theodore G.",
                    "initial": "T.G.",
                    "last": "Ganiats"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Hoberman"
                },
                {
                    "first": "Mary Anne",
                    "initial": "M.A.",
                    "last": "Jackson"
                },
                {
                    "first": "Mark D.",
                    "initial": "M.D.",
                    "last": "Joffe"
                },
                {
                    "first": "Donald T.",
                    "initial": "D.T.",
                    "last": "Miller"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Rosenfeld"
                },
                {
                    "first": "Xavier D.",
                    "initial": "X.D.",
                    "last": "Sevilla"
                },
                {
                    "first": "Richard H.",
                    "initial": "R.H.",
                    "last": "Schwartz"
                },
                {
                    "first": "Pauline A.",
                    "initial": "P.A.",
                    "last": "Thomas"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Tunkel"
                }
            ],
            "doi": "10.1542/peds.2012-3488",
            "firstpage": "e964",
            "issn": "00314005",
            "lastpage": "e999",
            "pmid": "23439909",
            "pub_year": 2013,
            "title": "The diagnosis and management of acute otitis media",
            "volume": "131"
        },
        "b0230": {
            "authors": [
                {
                    "first": "M. Nadeem",
                    "initial": "M.N.",
                    "last": "Khan"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Pichichero"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.02.023",
            "firstpage": "2900",
            "issn": "0264410X",
            "lastpage": "2907",
            "pmid": "22349524",
            "pub_year": 2012,
            "title": "Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans",
            "volume": "30"
        },
        "b0235": null
    },
    "body_text": [
        {
            "endOffset": 38802,
            "parents": [],
            "secId": "s0050",
            "sentence": "We were unable to quantify the functional response of anti-Ply antibodies (i.e., the inhibition of Ply hemolysis activity) because of issues with assay stability.",
            "startOffset": 38640,
            "title": "Discussion"
        },
        {
            "endOffset": 34240,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "For ALRI endpoints, VE seemed to be higher with lower post-primary anti-Ply antibody levels but VE point estimates remained positive for both low and high antibody ranges (Supplemental Table 6).",
            "startOffset": 34046,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 42180,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 42179,
                    "startOffset": 42172
                },
                "b0215": {
                    "endOffset": 42179,
                    "startOffset": 42172
                }
            },
            "secId": "s0050",
            "sentence": "At the time the study was designed, the available data suggested that around a quarter of AOM was pneumococcal; however, the burden of pneumococcal AOM, particularly amongst cases of recurrent AOM, has continued to decline in the PCV era and more recent data suggest an increasing role of other pathogens, particularly H. influenzae [42,43].",
            "startOffset": 41839,
            "title": "Discussion"
        },
        {
            "endOffset": 27366,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Participants in this sub-cohort also had blood collected at five timepoints (prior to dose 1, one month post-dose 3, prior to the booster vaccination, one month and 12 months post-booster vaccination).",
            "startOffset": 27165,
            "title": "Study procedures"
        },
        {
            "endOffset": 28409,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Based on 1800 enrolled participants (i.e., 1537 projected evaluable participants), the study had 97.2% power to demonstrate AOM VE >0% based on a true VE of 17%, an incidence rate in the control group of 0.6 episodes per child-year, an over-dispersion of 1.4 and a one-sided test, nominal type I error of 17.8%.",
            "startOffset": 28098,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 29695,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "VE was defined as (1 \u2212 hazard ratio) \u00d7 100%.",
            "startOffset": 29651,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 46967,
            "parents": [],
            "secId": "s0050",
            "sentence": "Because of these circumstances the events were not included in the clinical study database although they were reported to ABS.",
            "startOffset": 46841,
            "title": "Discussion"
        },
        {
            "endOffset": 41262,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 41261,
                    "startOffset": 41257
                }
            },
            "secId": "s0050",
            "sentence": "Other studies have shown potential protection by pneumococcal proteins, including PhtD and Ply, against AOM in a murine model; however, these findings might not translate to humans [40].",
            "startOffset": 41076,
            "title": "Discussion"
        },
        {
            "endOffset": 23383,
            "parents": [],
            "secId": "s0010",
            "sentence": "We conducted this study between May 2012 and July 2016 at five sites on the Navajo Nation and White Mountain Apache tribal lands in the southwest United States.",
            "startOffset": 23223,
            "title": "Material and methods"
        },
        {
            "endOffset": 25212,
            "parents": [],
            "secId": "s0010",
            "sentence": "The placebo contained 500 \u00b5g aluminum phosphate.",
            "startOffset": 25164,
            "title": "Material and methods"
        },
        {
            "endOffset": 41075,
            "parents": [],
            "secId": "s0050",
            "sentence": "Pre-clinical studies did not examine the effect of GSK\u2019s dPly or PhtD antigens on AOM.",
            "startOffset": 40989,
            "title": "Discussion"
        },
        {
            "endOffset": 36138,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Twelve months post-booster vaccination, anti-Ply antibody GMCs in the dPly/PhtD group waned but remained higher compared to the Control group; while anti-PhtD antibody GMCs were within the same range for both groups.",
            "startOffset": 35922,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 21429,
            "parents": [],
            "secId": "s0005",
            "sentence": "While use of PCVs has greatly reduced the burden of IPD, disparities persist.",
            "startOffset": 21352,
            "title": "Introduction"
        },
        {
            "endOffset": 41579,
            "parents": [],
            "secId": "s0050",
            "sentence": "The study was powered to detect an incremental VE of 17% or greater against the syndrome of AOM; this may have been too high a bar given that the dPly/PhtD vaccine was being co-administered with PCV13.",
            "startOffset": 41378,
            "title": "Discussion"
        },
        {
            "endOffset": 34783,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "No consistent impact of seasonal influenza vaccination was observed on dPly/PhtD efficacy against AOM and ALRI endpoints across the four winter seasons encompassed during the study (Supplemental Fig. 5).",
            "startOffset": 34580,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 42676,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 42675,
                    "startOffset": 42671
                }
            },
            "secId": "s0050",
            "sentence": "We attempted to minimize incorrect AOM diagnoses by training providers on the diagnosis of AOM through in-person sessions at the start of the study and online refresher modules during the study, and by using a standardized template for capture of AOM outcomes that included all relevant elements of the history and exam [44].",
            "startOffset": 42351,
            "title": "Discussion"
        },
        {
            "endOffset": 44229,
            "parents": [],
            "secId": "s0050",
            "sentence": "This finding, along with the observed antibody profiles over the course of the study, prompted us to conduct a post-hoc analysis in the mATP cohort of VE against first AOM and first MA-ALRI events at age <12 months.",
            "startOffset": 44014,
            "title": "Discussion"
        },
        {
            "endOffset": 40444,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 40443,
                    "startOffset": 40439
                }
            },
            "secId": "s0050",
            "sentence": "In a prospective study of 100 healthy infants 6\u201324 months of age, higher mucosal antibody levels to PhtD and dPly correlated with reduced risk of development of pneumococcal AOM in children, although no significant difference was found in mucosal antibody levels to PhtD and dPly between children with and without pneumococcal carriage [39].",
            "startOffset": 40103,
            "title": "Discussion"
        },
        {
            "endOffset": 23961,
            "parents": [],
            "secId": "s0010",
            "sentence": "Written informed consent was obtained from a parent or legally-authorized representative of each infant before enrollment.",
            "startOffset": 23839,
            "title": "Material and methods"
        },
        {
            "endOffset": 29650,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 29649,
                    "startOffset": 29645
                }
            },
            "secId": "s0025",
            "sentence": "Time-to-occurrence of primary endpoint events during the defined efficacy follow-up period was compared between groups by estimating VE and its 95% confidence interval (CI) using the Anderson & Gill model, with a robust sandwich estimator for variance matrix considered as a generalization of the Cox proportional hazard model, taking into account recurrent events [32].",
            "startOffset": 29280,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 22354,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 22353,
                    "startOffset": 22343
                },
                "b0070": {
                    "endOffset": 22353,
                    "startOffset": 22343
                },
                "b0075": {
                    "endOffset": 22353,
                    "startOffset": 22343
                },
                "b0080": {
                    "endOffset": 22353,
                    "startOffset": 22343
                },
                "b0085": {
                    "endOffset": 22353,
                    "startOffset": 22343
                },
                "b0090": {
                    "endOffset": 22353,
                    "startOffset": 22343
                }
            },
            "secId": "s0005",
            "sentence": "Alone or in combination Ply and PhtD have demonstrated protection against pneumococcal disease or carriage in in vitro and animal studies and were selected by GSK for clinical development [12,14\u201318].",
            "startOffset": 22155,
            "title": "Introduction"
        },
        {
            "endOffset": 40013,
            "parents": [],
            "secId": "s0050",
            "sentence": "In a post-hoc analysis, we did not find any evidence to suggest that pre-vaccination antibody interfered with dPly/PhtD immunogenicity.",
            "startOffset": 39878,
            "title": "Discussion"
        },
        {
            "endOffset": 23202,
            "parents": [],
            "secId": "s0005",
            "sentence": "We also report immunogenicity of dPly/PhtD antigens and safety/reactogenicity of the dPly/PhtD vaccine.",
            "startOffset": 23099,
            "title": "Introduction"
        },
        {
            "endOffset": 37395,
            "parents": [],
            "secId": "s0050",
            "sentence": "Several other studies have investigated the impact of protein-based or whole cell vaccines against colonization endpoints in humans, but to our knowledge, this was the first study designed to evaluate an effect of pneumococcal proteins against disease in humans as a primary endpoint.",
            "startOffset": 37111,
            "title": "Discussion"
        },
        {
            "endOffset": 38264,
            "parents": [],
            "secId": "s0050",
            "sentence": "In spite of the lack of demonstrated efficacy we observed a robust serum antibody response to the protein antigens.",
            "startOffset": 38149,
            "title": "Discussion"
        },
        {
            "endOffset": 45575,
            "parents": [],
            "secId": "s0050",
            "sentence": "Dispersed biofilm bacteria have increased virulence; animal models that evaluate the impact of anti-protein antibodies on disease using broth-grown bacteria, as opposed to dispersed biofilm bacteria, may not accurately reflect pathogenesis in humans.",
            "startOffset": 45325,
            "title": "Discussion"
        },
        {
            "endOffset": 20947,
            "parents": [],
            "secId": "s0005",
            "sentence": "However, currently available vaccines protect against only a fraction of the more than 90 pneumococcal serotypes.",
            "startOffset": 20834,
            "title": "Introduction"
        },
        {
            "endOffset": 25498,
            "parents": [],
            "secId": "s0010",
            "sentence": "Co-administered PCV13 was given intramuscularly on the opposite side.",
            "startOffset": 25429,
            "title": "Material and methods"
        },
        {
            "endOffset": 39196,
            "parents": [],
            "secId": "s0050",
            "sentence": "Levels of anti-PhtD antibody were similar at 12 months of age and, although there was an increase in antibody GMCs one month-post booster in dPly/PhtD recipients compared to the Control group, levels were similar again by 24-months of age.",
            "startOffset": 38957,
            "title": "Discussion"
        },
        {
            "endOffset": 22777,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 22776,
                    "startOffset": 22769
                },
                "b0100": {
                    "endOffset": 22776,
                    "startOffset": 22769
                },
                "b0105": {
                    "endOffset": 22776,
                    "startOffset": 22769
                },
                "b0110": {
                    "endOffset": 22776,
                    "startOffset": 22769
                }
            },
            "secId": "s0005",
            "sentence": "Vaccines containing dPly (a pneumolysin toxoid), PhtD and 10 serotype-specific polysaccharide conjugates of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, Synflorix, GSK) were found to be immunogenic and well-tolerated in children and infants; however, efficacy against pneumococcal nasopharyngeal carriage prevalence, density, acquisition or clearance was not observed [19\u201322].",
            "startOffset": 22355,
            "title": "Introduction"
        },
        {
            "endOffset": 43596,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 43595,
                    "startOffset": 43591
                }
            },
            "secId": "s0050",
            "sentence": "Reassuringly, the incidence rate of AOM in this study (0.43\u20130.44 episodes/child-year) was similar to that documented by tympanocentesis among children aged 6\u201336 months in Rochester, New York with AAP-AOM [2013] in the PCV era (0.38 episodes/child-year during the first year of life and 0.48 episodes/child-year during the second year of life) [42].",
            "startOffset": 43248,
            "title": "Discussion"
        },
        {
            "endOffset": 28470,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The interim analysis is presented in the Supplementary Text.",
            "startOffset": 28410,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 21852,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 21851,
                    "startOffset": 21847
                }
            },
            "secId": "s0005",
            "sentence": "Protein antigens that are conserved across pneumococcal serotypes may offer an alternative to serotype-restricted vaccination strategies [10].",
            "startOffset": 21710,
            "title": "Introduction"
        },
        {
            "endOffset": 24200,
            "parents": [],
            "secId": "s0010",
            "sentence": "A protocol summary is available at www.gsk-studyregister.com (study ID: 115597).",
            "startOffset": 24120,
            "title": "Material and methods"
        },
        {
            "endOffset": 47191,
            "parents": [],
            "secId": "s0050",
            "sentence": "The study was not powered to detect a difference in IPD outcomes and the work-up for possible invasive bacterial infection was done at the discretion of the child\u2019s provider, rather than systematically as part of the study.",
            "startOffset": 46968,
            "title": "Discussion"
        },
        {
            "endOffset": 29896,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Antibody geometric mean concentrations (GMCs) and percentage of infants with antibody concentration above pre-specified cut-offs (12 ELISA units[EL.U]/mL for Ply and 17 EL.U/mL for PhtD) were assessed.",
            "startOffset": 29695,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 22154,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 22153,
                    "startOffset": 22146
                },
                "b0060": {
                    "endOffset": 22153,
                    "startOffset": 22146
                },
                "b0065": {
                    "endOffset": 22153,
                    "startOffset": 22146
                }
            },
            "secId": "s0005",
            "sentence": "Two such proteins are pneumolysin (Ply) \u2013 a cytolytic protein that contributes to the host inflammatory response, facilitates colonization and plays a role in acute lung injury \u2013 and pneumococcal histidine triad protein D (PhtD), which has a role in ion homeostasis and pneumococcal virulence [11\u201313].",
            "startOffset": 21853,
            "title": "Introduction"
        },
        {
            "endOffset": 37110,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 37109,
                    "startOffset": 37096
                },
                "b0080": {
                    "endOffset": 37109,
                    "startOffset": 37096
                },
                "b0085": {
                    "endOffset": 37109,
                    "startOffset": 37096
                },
                "b0180": {
                    "endOffset": 37109,
                    "startOffset": 37096
                }
            },
            "secId": "s0050",
            "sentence": "In pre-clinical studies, Ply and PhtD, administered either separately or in combination, provided protection against pneumococcal carriage and disease, including pneumonia in macaques [12,16,17,36].",
            "startOffset": 36912,
            "title": "Discussion"
        },
        {
            "endOffset": 27164,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Solicited local and general AEs were documented on a diary card during 4 days post-vaccination by the parent/guardian of each participant in the immunogenicity/reactogenicity sub-cohort.",
            "startOffset": 26978,
            "title": "Study procedures"
        },
        {
            "endOffset": 44352,
            "parents": [],
            "secId": "s0050",
            "sentence": "There was a suggestion of incremental VE of dPly/PhtD vaccine beyond that of PCV13, which was more pronounced for MA-ALRI.",
            "startOffset": 44230,
            "title": "Discussion"
        },
        {
            "endOffset": 40584,
            "parents": [],
            "secId": "s0050",
            "sentence": "Results were not stratified by episode number so it is unclear if these findings were similar between first and subsequent episodes of AOM.",
            "startOffset": 40445,
            "title": "Discussion"
        },
        {
            "endOffset": 47375,
            "parents": [],
            "secId": "s0050",
            "sentence": "In conclusion, this study showed that vaccination with dPly and PhtD antigens was well-tolerated and immunogenic but did not show additional protection to children against AOM or ALRI.",
            "startOffset": 47191,
            "title": "Discussion"
        },
        {
            "endOffset": 26300,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "In addition, we report on the following secondary objectives: the safety of the dPly/PhtD vaccine in all participants in terms of serious adverse events (SAEs) and the immunogenicity and reactogenicity of the dPly/PhtD vaccine in a sub-cohort of participants.",
            "startOffset": 26041,
            "title": "Study endpoints"
        },
        {
            "endOffset": 47747,
            "parents": [],
            "secId": "s0055",
            "sentence": "13/Prevnar 13 is a trademark of Pfizer, Inc.",
            "startOffset": 47703,
            "title": "Trademark statement"
        },
        {
            "endOffset": 41838,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 41734,
                    "startOffset": 41730
                }
            },
            "secId": "s0050",
            "sentence": "The reported VE of licensed PCVs against clinical AOM assessed in clinical trials ranged up to a 15% reduction, but was non-statistically significant [41]; we used a slightly higher estimated VE given the serotype-independent nature of the dPly/PhtD vaccine.",
            "startOffset": 41580,
            "title": "Discussion"
        },
        {
            "endOffset": 31195,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For each participant, VE follow-up duration for a given season was defined as shown in Supplemental Fig. 1.",
            "startOffset": 31088,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 38956,
            "parents": [],
            "secId": "s0050",
            "sentence": "For anti-PhtD, an increase in antibody GMCs one month post-dose 3 was observed compared to baseline; whereas antibody GMCs in the Control group declined.",
            "startOffset": 38803,
            "title": "Discussion"
        },
        {
            "endOffset": 21048,
            "parents": [],
            "secId": "s0005",
            "sentence": "Streptococcus pneumoniae remains an important cause of IPD, pneumonia, and acute otitis media (AOM).",
            "startOffset": 20948,
            "title": "Introduction"
        },
        {
            "endOffset": 24837,
            "parents": [],
            "secId": "s0010",
            "sentence": "All study participants, investigators, funding staff, and monitoring staff were masked to drug allocation.",
            "startOffset": 24731,
            "title": "Material and methods"
        },
        {
            "endOffset": 24119,
            "parents": [],
            "secId": "s0010",
            "sentence": "This study was registered at www.clinicaltrials.gov (NCT01545375).",
            "startOffset": 24053,
            "title": "Material and methods"
        },
        {
            "endOffset": 45324,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 45323,
                    "startOffset": 45319
                }
            },
            "secId": "s0050",
            "sentence": "Although not assessed in this study, biofilms are typically associated with recurrent infections and allow bacteria to resist host immune responses [47].",
            "startOffset": 45171,
            "title": "Discussion"
        },
        {
            "endOffset": 32350,
            "parents": [],
            "secId": "s0030",
            "sentence": "In the mATP cohort for efficacy, 485 AAP-AOM events were detected in the dPly/PhtD group and 518 in the Control group, giving an incidence of 0.43 and 0.44 episodes/child-year, respectively (Table 2); the proportion of participants experiencing 3 or more episodes of AAP-AOM was 5.1% in the dPly/PhtD group and 4.8% in the Control group.",
            "startOffset": 32013,
            "title": "Results"
        },
        {
            "endOffset": 26977,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Immunogenicity and unsolicited adverse events (AEs) occurring within one month following administration of each dose of study vaccine were assessed in the immunogenicity/reactogenicity sub-cohort (N = 400).",
            "startOffset": 26771,
            "title": "Study procedures"
        },
        {
            "endOffset": 33681,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "This finding was more pronounced in a post-hoc analysis restricted to first episodes within the first year of life (Fig. 3; Supplemental Figs. 2 and 3; Supplemental Table 5).",
            "startOffset": 33507,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 47694,
            "parents": [],
            "secId": "s0055",
            "sentence": "Synflorix is a trademark of the GSK group of companies.",
            "startOffset": 47639,
            "title": "Trademark statement"
        },
        {
            "endOffset": 23485,
            "parents": [],
            "secId": "s0010",
            "sentence": "Health care is administered free of charge to tribal members through the Indian Health Service (IHS).",
            "startOffset": 23384,
            "title": "Material and methods"
        },
        {
            "endOffset": 33506,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "VE against first episodes of clinical AOM or ALRI tended to be higher compared to VE against all episodes (Tables 2 and 3).",
            "startOffset": 33383,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 47810,
            "parents": [],
            "secId": "s0060",
            "sentence": "This study was funded by GlaxoSmithKline Biologicals SA.",
            "startOffset": 47754,
            "title": "Funding"
        },
        {
            "endOffset": 46444,
            "parents": [],
            "secId": "s0050",
            "sentence": "IPD events, which were identified through the surveillance for SAEs since they were not disease outcome events in the protocol, were more common in the dPly/PhtD group (n = 5) compared to the Control group (n = 1), although this was not a statistically significant difference.",
            "startOffset": 46168,
            "title": "Discussion"
        },
        {
            "endOffset": 31087,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The influenza season was defined from November 30 to May 31 and, in any given season, VE against AOM and ALRI endpoints was assessed in the total vaccinated cohort (TVC) and mATP cohort for efficacy.",
            "startOffset": 30888,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 33230,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "VE against all episodes of draining AOM, pneumococcal draining AOM, and non-pneumococcal draining AOM ranged from \u201332.2% (\u2212298.3, 56.1) to 17.8% (\u221257.0, 57.0) (Supplemental Table 4).",
            "startOffset": 33048,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 42350,
            "parents": [],
            "secId": "s0050",
            "sentence": "Accurately diagnosing AOM can be challenging and overdiagnosis of AOM is common; inclusion of events that were not truly AOM would reduce the ability to detect efficacy.",
            "startOffset": 42181,
            "title": "Discussion"
        },
        {
            "endOffset": 36425,
            "parents": [],
            "secId": "s0050",
            "sentence": "Currently available pneumococcal vaccines do not include antigens against all pneumococcal serotypes.",
            "startOffset": 36324,
            "title": "Discussion"
        },
        {
            "endOffset": 34579,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "AOM incidence followed a seasonal pattern with peaks in winter seasons and tended to be lower in the last season of the study, reflecting the older age of the study population (Supplemental Fig. 4).",
            "startOffset": 34381,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 36912,
            "parents": [],
            "secId": "s0050",
            "sentence": "In this study, dPly/PhtD vaccine was immunogenic and had an acceptable reactogenicity and safety profile after primary and booster vaccination when co-administered with PCV13; however, we did not observe significant efficacy against any of the pre-defined AOM or ALRI endpoints.",
            "startOffset": 36634,
            "title": "Discussion"
        },
        {
            "endOffset": 43754,
            "parents": [],
            "secId": "s0050",
            "sentence": "Nevertheless, AOM may still have been mis- or overdiagnosed, which could have resulted in the study being underpowered and biased toward the null hypothesis.",
            "startOffset": 43597,
            "title": "Discussion"
        },
        {
            "endOffset": 36633,
            "parents": [],
            "secId": "s0050",
            "sentence": "Vaccines that offer serotype-independent protection, such as those targeting conserved proteins that are common to most or all pneumococcal strains, could substantially reduce global morbidity and mortality.",
            "startOffset": 36426,
            "title": "Discussion"
        },
        {
            "endOffset": 47619,
            "parents": [],
            "secId": "s0050",
            "sentence": "Future studies should aim to improve our understanding of the effect of anti-protein antibodies on pathogenesis of pneumococcal disease.",
            "startOffset": 47483,
            "title": "Discussion"
        },
        {
            "endOffset": 24536,
            "parents": [],
            "secId": "s0010",
            "sentence": "A subset of children was enrolled into the immunogenicity/reactogenicity sub-cohort.",
            "startOffset": 24452,
            "title": "Material and methods"
        },
        {
            "endOffset": 35696,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "In the ATP immunogenicity cohort (N = 124/group), all children had anti-Ply and anti-PhtD antibody concentrations above the LLOQ of the assay at all timepoints.",
            "startOffset": 35536,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 24730,
            "parents": [],
            "secId": "s0010",
            "sentence": "Randomization was stratified by site with a block size of six and treatment allocation at the investigator site for dPly/PhtD was performed using a central randomization system on the internet.",
            "startOffset": 24537,
            "title": "Material and methods"
        },
        {
            "endOffset": 32986,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "In the mATP cohort for VE, VE against all AAP-AOM episodes was 3.8% (95% CI: \u221211.4, 16.9).",
            "startOffset": 32896,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 40988,
            "parents": [],
            "secId": "s0050",
            "sentence": "There are several possible reasons that efficacy was not observed, despite very good serum antibody responses to the dPly/PhtD vaccine.",
            "startOffset": 40853,
            "title": "Discussion"
        },
        {
            "endOffset": 24384,
            "parents": [],
            "secId": "s0010",
            "sentence": "Eligible infants aged 6\u201312 weeks were randomized 1:1 to receive dPly/PhtD vaccine or placebo (Control group) at ages 2, 4, 6 and 12\u201315 months, each co-administered with PCV13 (Fig. 1).",
            "startOffset": 24200,
            "title": "Material and methods"
        },
        {
            "endOffset": 39877,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 39876,
                    "startOffset": 39867
                },
                "b0185": {
                    "endOffset": 39876,
                    "startOffset": 39867
                },
                "b0190": {
                    "endOffset": 39876,
                    "startOffset": 39867
                }
            },
            "secId": "s0050",
            "sentence": "The high baseline anti-protein antibody levels in this study presumably result from exposure at a young age or from maternal antibody transfer in utero, both of which are plausible given the high burden of pneumococcal carriage and disease in this population [8,37,38].",
            "startOffset": 39608,
            "title": "Discussion"
        },
        {
            "endOffset": 32771,
            "parents": [],
            "secId": "s0030",
            "sentence": "There were 163 medically-attended (MA)-ALRI events in the dPly/PhtD group and 165 in the Control group, giving an incidence of 0.14 episodes/child-year in each group (Table 3).",
            "startOffset": 32595,
            "title": "Results"
        },
        {
            "endOffset": 42852,
            "parents": [],
            "secId": "s0050",
            "sentence": "During the course of the study, the AAP published updated criteria for diagnosis of AOM, which were intended to more clearly differentiate AOM from otitis media with effusion.",
            "startOffset": 42677,
            "title": "Discussion"
        },
        {
            "endOffset": 30887,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Therefore, we also assessed the effect of seasonality and influenza vaccination in a post-hoc exploratory analysis.",
            "startOffset": 30772,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 47703,
            "parents": [],
            "secId": "s0055",
            "sentence": "Prevenar",
            "startOffset": 47695,
            "title": "Trademark statement"
        },
        {
            "endOffset": 43247,
            "parents": [],
            "secId": "s0050",
            "sentence": "VE against episodes of AAP-AOM was similar using the 2004 and 2013 definitions; however, this analysis was limited because some details of the AOM events could not be collected retrospectively.",
            "startOffset": 43054,
            "title": "Discussion"
        },
        {
            "endOffset": 26770,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Active surveillance for any medical event was conducted by study staff at study facilities and other facilities providing care in the study communities starting from administration of the first dose through study end for each participant to identify SAEs and episodes of AOM or ALRI.",
            "startOffset": 26487,
            "title": "Study procedures"
        },
        {
            "endOffset": 20833,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 20832,
                    "startOffset": 20829
                }
            },
            "secId": "s0005",
            "sentence": "Routine use of licensed pneumococcal conjugate vaccines (PCVs) has led to a substantial reduction in invasive pneumococcal disease (IPD) among vaccinated and unvaccinated individuals [1].",
            "startOffset": 20646,
            "title": "Introduction"
        },
        {
            "endOffset": 46167,
            "parents": [],
            "secId": "s0050",
            "sentence": "The frequency of solicited and unsolicited AEs was similar in dPly/PhtD and Control participants after primary and booster vaccination.",
            "startOffset": 46032,
            "title": "Discussion"
        },
        {
            "endOffset": 38149,
            "parents": [],
            "secId": "s0050",
            "sentence": "It has been suggested that the absence of an effect on carriage in infants in The Gambia may be a consequence of the acquisition of carriage early in life, along with other risk factors for high density carriage; however, populations with a high force of infection and a variety of risk factors are precisely where new vaccines are needed most.",
            "startOffset": 37805,
            "title": "Discussion"
        },
        {
            "endOffset": 40102,
            "parents": [],
            "secId": "s0050",
            "sentence": "It is important to acknowledge that this study measured serum but not mucosal antibodies.",
            "startOffset": 40013,
            "title": "Discussion"
        },
        {
            "endOffset": 26468,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Results of other objectives (i.e., immunogenicity of co-administered pneumococcal and Hib vaccines, and bacterial nasopharyngeal carriage) will be described elsewhere.",
            "startOffset": 26301,
            "title": "Study endpoints"
        },
        {
            "endOffset": 33047,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "VE against the first AAP-AOM episode was 11.3% (\u22123.4, 23.9).",
            "startOffset": 32987,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 47482,
            "parents": [],
            "secId": "s0050",
            "sentence": "The interactions between immunity, carriage, and progression to disease are complex and poorly understood.",
            "startOffset": 47376,
            "title": "Discussion"
        },
        {
            "endOffset": 41377,
            "parents": [],
            "secId": "s0050",
            "sentence": "Additionally, differences in the production method might lead to antigenic differences that could affect efficacy.",
            "startOffset": 41263,
            "title": "Discussion"
        },
        {
            "endOffset": 25283,
            "parents": [],
            "secId": "s0010",
            "sentence": "The placebo was visually indistinguishable from the dPly/PhtD vaccine.",
            "startOffset": 25213,
            "title": "Material and methods"
        },
        {
            "endOffset": 43053,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 43052,
                    "startOffset": 43048
                }
            },
            "secId": "s0050",
            "sentence": "Because the study was ongoing, no changes to the study objectives were made apart from collection of new data to allow assessment of efficacy according to the updated definition (AAP-AOM [2013]) [45].",
            "startOffset": 42853,
            "title": "Discussion"
        },
        {
            "endOffset": 34381,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "VE against AOM and ALRI endpoints appeared in the same range for low and high post-primary anti-PhtD antibody levels (Supplemental Table 7).",
            "startOffset": 34241,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 27557,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 27556,
                    "startOffset": 27552
                }
            },
            "secId": "s0020",
            "sentence": "Samples were centrifuged and serum was stored at \u221220 \u00b0C or colder until assayed for anti-Ply and anti-PhtD antibodies by GSK using an in-house enzyme linked immunosorbent assay (ELISA) [25].",
            "startOffset": 27367,
            "title": "Study procedures"
        },
        {
            "endOffset": 25163,
            "parents": [],
            "secId": "s0010",
            "sentence": "The investigational pneumococcal vaccine (dPly/PhtD) contained dPly and PhtD at 10 \u00b5g each, adsorbed on aluminum phosphate (vaccine adjuvant; aluminum content 500 \u00b5g).",
            "startOffset": 24996,
            "title": "Material and methods"
        },
        {
            "endOffset": 27940,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 27939,
                    "startOffset": 27932
                },
                "b0135": {
                    "endOffset": 27939,
                    "startOffset": 27932
                },
                "b0140": {
                    "endOffset": 27939,
                    "startOffset": 27932
                }
            },
            "secId": "s0025",
            "sentence": "Sample size calculations were based on the assumption that, among AOM, approximately 60% is bacterial, of which 40% is pneumococcal [26\u201328].",
            "startOffset": 27800,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 30419,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 30418,
                    "startOffset": 30414
                }
            },
            "secId": "s0025",
            "sentence": "Because acquired maternal antibodies may inhibit the infant immune response to primary immunization, we assessed as exploratory analyses the relationship between pre- and post-immunization anti-Ply and anti-PhtD antibody levels using scatter plots [33].",
            "startOffset": 30166,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 31896,
            "parents": [],
            "secId": "s0030",
            "sentence": "808 infants in the Investigational group and 831 in the Control group were included in the mATP cohort for efficacy.",
            "startOffset": 31780,
            "title": "Results"
        },
        {
            "endOffset": 45896,
            "parents": [],
            "secId": "s0050",
            "sentence": "This post-hoc analysis did not show a consistent impact of influenza vaccination on the VE of dPly/PhtD against AOM and ALRI.",
            "startOffset": 45771,
            "title": "Discussion"
        },
        {
            "endOffset": 27799,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The primary objective was to demonstrate that the VE induced by the dPly/PhtD vaccine against clinical AOM diagnosed and verified using AAP criteria was greater than 0%, as compared to the Control group.",
            "startOffset": 27596,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 34967,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Pain and irritability were the most frequently reported solicited local and general symptoms, respectively, after primary and booster vaccination (Table 4).",
            "startOffset": 34811,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 46032,
            "parents": [],
            "secId": "s0050",
            "sentence": "The small number of children in the subsets and hence the low number of AOM and ALRI cases recorded are a limitation for this analysis.",
            "startOffset": 45897,
            "title": "Discussion"
        },
        {
            "endOffset": 24995,
            "parents": [],
            "secId": "s0010",
            "sentence": "dPly/PhtD vaccine and placebo were supplied to the site in identical-looking and -labelled vials in coded kits and stored at 2\u20138 \u00b0C until the time of dosing.",
            "startOffset": 24838,
            "title": "Material and methods"
        },
        {
            "endOffset": 32012,
            "parents": [],
            "secId": "s0030",
            "sentence": "Demographic characteristics and duration of follow-up were similar in the two groups (Supplemental Tables 1 and 2).",
            "startOffset": 31897,
            "title": "Results"
        },
        {
            "endOffset": 35519,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "IPD was reported from five children in the dPly/PhtD group and one in the Control group, all due to non-PCV13 types.",
            "startOffset": 35403,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 21710,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 21709,
                    "startOffset": 21704
                },
                "b0040": {
                    "endOffset": 21709,
                    "startOffset": 21704
                },
                "b0045": {
                    "endOffset": 21709,
                    "startOffset": 21704
                }
            },
            "secId": "s0005",
            "sentence": "Age-group specific IPD incidence among Native Americans in the southwest United States remains 2\u20134-fold higher than the general US population; the majority of this residual pneumococcal disease is caused by serotypes not covered by currently available pneumococcal vaccines [7\u20139].",
            "startOffset": 21430,
            "title": "Introduction"
        },
        {
            "endOffset": 35095,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Percentage of doses followed by at least one unsolicited and grade 3 unsolicited AEs were within similar ranges between groups.",
            "startOffset": 34968,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 37699,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 37698,
                    "startOffset": 37694
                }
            },
            "secId": "s0050",
            "sentence": "Among infants in The Gambia study, the inclusion of pneumococcal proteins plus 10 serotype-specific polysaccharide conjugates (PHiD-CV/dPly/PhtD), administered at 2, 3, 4 months or 2, 4, 9 months of age did not reduce the prevalence or density of pneumococcal carriage beyond the effect of PHiD-CV [20].",
            "startOffset": 37396,
            "title": "Discussion"
        },
        {
            "endOffset": 25788,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 25787,
                    "startOffset": 25783
                }
            },
            "secId": "s0010",
            "sentence": "All other vaccines were given according to the recommended childhood immunization schedule in the United States, including influenza vaccine for children \u22656 months old which was allowed during the influenza seasons, as per Advisory Committee on Immunization Practices recommendations [23].",
            "startOffset": 25499,
            "title": "Material and methods"
        },
        {
            "endOffset": 34045,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Exploratory analyses of VE against various AOM and ALRI endpoints among participants with low (\u226427498 EL.U/mL for Ply; \u22643739.5 EL.U/mL for PhtD) and high (>27498 EL.U/mL for Ply; >3739.5 EL.U/mL for PhtD) post-primary anti-protein antibody concentrations revealed a trend for higher efficacy against AOM endpoints with higher post-primary anti-Ply antibody levels.",
            "startOffset": 33681,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 43916,
            "parents": [],
            "secId": "s0050",
            "sentence": "In addition, culture of middle ear fluid to assess the etiology of draining AOM was done at the discretion of the clinical provider and not as a study procedure.",
            "startOffset": 43755,
            "title": "Discussion"
        },
        {
            "endOffset": 23098,
            "parents": [],
            "secId": "s0005",
            "sentence": "We report results of a phase IIb randomized controlled trial that assessed the incremental efficacy (over 13-valent PCV [PCV13], Prevenar 13/Prevnar 13, Pfizer) of an investigational pneumococcal protein-based vaccine, dPly/PhtD, against AOM and acute lower respiratory tract infection (ALRI) in Native American infants.",
            "startOffset": 22778,
            "title": "Introduction"
        },
        {
            "endOffset": 46840,
            "parents": [],
            "secId": "s0050",
            "sentence": "As part of a long-standing population-based Active Bacterial Surveillance (ABS) system for IPD at the study sites, two additional cases of IPD in participants from the Control group were identified: one in a participant who completed the study before IPD occurred at 31 months of age, and one in a participant that had withdrawn from the study prior to the occurrence of IPD at 25 months of age.",
            "startOffset": 46445,
            "title": "Discussion"
        },
        {
            "endOffset": 29216,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The primary efficacy analysis was based on (i) the occurrence of the primary endpoint (i.e., AAP-AOM 2004) anytime from two weeks after the administration of the third primary dose of the study vaccine up to the final study visit or the time of censoring (e.g., for participants with non-compliance with the protocol) or up to the time of withdrawal (e.g., if a participant withdrew before completing the study) and (ii) the modified according-to-protocol (mATP) cohort for efficacy analysis which included all participants from the ATP cohort for efficacy analysis and participants for whom non-compliance with the vaccination intervals during primary vaccination constituted the only elimination criterion from ATP cohort for efficacy analysis.",
            "startOffset": 28470,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 31361,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "VE was computed within each subgroup (seasonal influenza-vaccinated or seasonal influenza-unvaccinated) to assess the efficacy of dPly/PhtD versus the Control group.",
            "startOffset": 31196,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 26040,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 26039,
                    "startOffset": 26035
                }
            },
            "secId": "s0015",
            "sentence": "We assessed dPly/PhtD vaccine efficacy (VE) against all episodes of clinically diagnosed AOM meeting the 2004 American Academy of Pediatrics criteria (AAP-AOM [2004]; primary objective) and other AOM and ALRI endpoints (Table 1) [24].",
            "startOffset": 25806,
            "title": "Study endpoints"
        },
        {
            "endOffset": 23838,
            "parents": [],
            "secId": "s0010",
            "sentence": "The study was conducted in accordance with Good Clinical Practice guidelines and the principles of the Declaration of Helsinki.",
            "startOffset": 23711,
            "title": "Material and methods"
        },
        {
            "endOffset": 30622,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Further, the impact of post-primary series anti-Ply and anti-PhtD antibody levels on VE was assessed by dividing participants into \u201clow\u201d and \u201chigh\u201d categories based on the median antibody concentration.",
            "startOffset": 30420,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 44525,
            "parents": [],
            "secId": "s0050",
            "sentence": "Compared to the Control group, dPly/PhtD vaccine recipients had higher antibody GMCs to PhtD at 7 months of age, but this difference was no longer evident by 1 year of age.",
            "startOffset": 44353,
            "title": "Discussion"
        },
        {
            "endOffset": 21243,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 21242,
                    "startOffset": 21237
                },
                "b0010": {
                    "endOffset": 21242,
                    "startOffset": 21237
                }
            },
            "secId": "s0005",
            "sentence": "In 2015, there were an estimated 3.7 million episodes of severe pneumococcal disease globally, in a setting where 129 countries had included PCV as part of the infant vaccination programs [1,2].",
            "startOffset": 21049,
            "title": "Introduction"
        },
        {
            "endOffset": 31779,
            "parents": [],
            "secId": "s0030",
            "sentence": "Of the 1803 infants in the TVC, 900 were in the Investigational group (dPly/PhtD + PCV13) and 903 in the Control group (Placebo + PCV13) (Fig. 2).",
            "startOffset": 31633,
            "title": "Results"
        },
        {
            "endOffset": 38639,
            "parents": [],
            "secId": "s0050",
            "sentence": "Because values above the assay ULOQ were assigned as the ULOQ value, the anti-Ply antibody GMCs for dPly/PhtD recipients are underestimated.",
            "startOffset": 38499,
            "title": "Discussion"
        },
        {
            "endOffset": 23710,
            "parents": [],
            "secId": "s0010",
            "sentence": "The institutional review boards of the Johns Hopkins Bloomberg School of Public Health, the Navajo Nation, the Phoenix Area Indian Health Service, and the Tribal Council of the White Mountain Apache Tribe approved the study.",
            "startOffset": 23486,
            "title": "Material and methods"
        },
        {
            "endOffset": 45054,
            "parents": [],
            "secId": "s0050",
            "sentence": "However, the lack of consistent and statistically significant findings limits our ability to make conclusions.",
            "startOffset": 44944,
            "title": "Discussion"
        },
        {
            "endOffset": 31501,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "VE was estimated using the generalized Cox regression model, by using time-to-event; the point estimates were not adjusted for multiplicity.",
            "startOffset": 31361,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 40853,
            "parents": [],
            "secId": "s0050",
            "sentence": "While the study presented herein did not measure mucosal antibodies \u2013 a step that should be considered in future studies of pneumococcal protein vaccines \u2013 the serum antibody levels intimate that mucosal levels were also likely high among dPly/PhtD vaccine recipients.",
            "startOffset": 40585,
            "title": "Discussion"
        },
        {
            "endOffset": 32518,
            "parents": [],
            "secId": "s0030",
            "sentence": "5.7% and 5.9% of children experienced recurrent AOM diagnosed by a health-care provider (HCP) in the dPly/PhtD and Control groups, respectively (Supplemental Table 3).",
            "startOffset": 32351,
            "title": "Results"
        },
        {
            "endOffset": 35921,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Antibody GMCs for both antigens were higher in the dPly/PhtD group than the Control group one month post-primary and post-booster vaccination and increased after primary and booster vaccination compared to baseline (Fig. 4).",
            "startOffset": 35697,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 45770,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 45667,
                    "startOffset": 45660
                },
                "b0175": {
                    "endOffset": 45667,
                    "startOffset": 45660
                }
            },
            "secId": "s0050",
            "sentence": "Because influenza vaccination and season might impact the incidences of AOM and ALRI [34,35], we also conducted an exploratory analysis to understand their potential impact on dPly/PhtD efficacy.",
            "startOffset": 45575,
            "title": "Discussion"
        },
        {
            "endOffset": 24451,
            "parents": [],
            "secId": "s0010",
            "sentence": "Inclusion and exclusion criteria are listed in Supplementary Text.",
            "startOffset": 24385,
            "title": "Material and methods"
        },
        {
            "endOffset": 39607,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 39606,
                    "startOffset": 39599
                },
                "b0110": {
                    "endOffset": 39606,
                    "startOffset": 39599
                }
            },
            "secId": "s0050",
            "sentence": "The pattern of anti-protein antibody responses was similar to findings in infants in The Gambia and in Europe, although the GMCs were substantially higher in the Native American infants at baseline (pre-vaccination) and post-primary vaccination compared to European infants who received dPly/PhtD containing vaccine at 2, 3, 4 and 12\u201315 months and Gambian infants who were vaccinated at 2, 3, 4 months [20,22].",
            "startOffset": 39197,
            "title": "Discussion"
        },
        {
            "endOffset": 28097,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 28096,
                    "startOffset": 28086
                },
                "b0145": {
                    "endOffset": 28096,
                    "startOffset": 28086
                },
                "b0150": {
                    "endOffset": 28096,
                    "startOffset": 28086
                },
                "b0155": {
                    "endOffset": 28096,
                    "startOffset": 28086
                }
            },
            "secId": "s0025",
            "sentence": "True VE against pneumococcal AOM was estimated to be similar to the observed PCV VE against vaccine-type pneumococcal AOM (approximately 50\u201360%) [26,29\u201331].",
            "startOffset": 27941,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 30771,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0170": {
                    "endOffset": 30770,
                    "startOffset": 30763
                },
                "b0175": {
                    "endOffset": 30770,
                    "startOffset": 30763
                }
            },
            "secId": "s0025",
            "sentence": "Influenza disease and vaccination may impact the incidence of AOM and ALRI, and may consequently bias estimates of VE against these diseases [34,35].",
            "startOffset": 30622,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 35206,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "SAEs were reported from 229/900 (25.4%) dPly/PhtD and 232/903 (25.7%) Control children (Supplemental Table 8).",
            "startOffset": 35096,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 44013,
            "parents": [],
            "secId": "s0050",
            "sentence": "Efficacy tended to be higher against first AOM and ALRI episodes compared to subsequent episodes.",
            "startOffset": 43916,
            "title": "Discussion"
        },
        {
            "endOffset": 29280,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The other cohorts analyzed are described in Supplementary Text.",
            "startOffset": 29217,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 36313,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "In exploratory analyses, we did not detect a clear relationship between pre- and post-primary vaccination anti-Ply and anti-PhtD antibody concentration (Supplemental Fig. 6).",
            "startOffset": 36139,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 33382,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "VE against all episodes of MA-ALRI, MA-ALRI with fever, and MA-HCP-ALRI with fever ranged between \u22124.4% (\u221239.2, 21.8) and 2.0% (\u221218.3, 18.8) (Table 3).",
            "startOffset": 33231,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 30166,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For the purpose of GMC calculation, antibody concentrations below the lower limit of quantification (LLOQ) of the assay were given an arbitrary value of half the LLOQ and those above the upper limit of quantification (ULOQ) were assigned a value equivalent to the ULOQ.",
            "startOffset": 29897,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 32895,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Incremental efficacy of dPly/PhtD in preventing AAP-AOM (2004) over PCV13 was not demonstrated (Table 2).",
            "startOffset": 32790,
            "title": "Vaccine efficacy"
        },
        {
            "endOffset": 44943,
            "parents": [],
            "secId": "s0050",
            "sentence": "It is possible that the trend toward greater protection among dPly/PhtD vaccine recipients against first AOM or ALRI episodes in the first year of life relates to the notable difference in anti-PhtD levels, and that this clinical benefit was no longer evident when levels became more similar to those of the Control group.",
            "startOffset": 44621,
            "title": "Discussion"
        },
        {
            "endOffset": 44620,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 44619,
                    "startOffset": 44615
                }
            },
            "secId": "s0050",
            "sentence": "PhtD plays a role in adherence of S. pneumoniae to human nasopharyngeal epithelial cells [46].",
            "startOffset": 44526,
            "title": "Discussion"
        },
        {
            "endOffset": 21351,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 21350,
                    "startOffset": 21345
                },
                "b0020": {
                    "endOffset": 21350,
                    "startOffset": 21345
                },
                "b0025": {
                    "endOffset": 21350,
                    "startOffset": 21345
                },
                "b0030": {
                    "endOffset": 21350,
                    "startOffset": 21345
                }
            },
            "secId": "s0005",
            "sentence": "Prior to the use of PCVs, the rate of IPD among Native Americans was one of the highest in the world [3\u20136].",
            "startOffset": 21244,
            "title": "Introduction"
        },
        {
            "endOffset": 35402,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Vaccination-related SAEs were reported from two children in the dPly/PhtD group (pyrexia plus diarrhea and pyrexia) and one in the Control group (febrile convulsion); no fatal SAEs were reported.",
            "startOffset": 35207,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 37804,
            "parents": [],
            "secId": "s0050",
            "sentence": "The reasons for the differences in outcomes between animal models and human clinical trials are unclear.",
            "startOffset": 37700,
            "title": "Discussion"
        },
        {
            "endOffset": 38399,
            "parents": [],
            "secId": "s0050",
            "sentence": "Antibody levels to the Ply component were substantially higher in the dPly/PhtD group compared to the Control group at all timepoints.",
            "startOffset": 38265,
            "title": "Discussion"
        },
        {
            "endOffset": 24052,
            "parents": [],
            "secId": "s0010",
            "sentence": "An independent data monitoring committee was charged with oversight of participant safety.",
            "startOffset": 23962,
            "title": "Material and methods"
        },
        {
            "endOffset": 32594,
            "parents": [],
            "secId": "s0030",
            "sentence": "For both groups, the peak incidence of AOM occurred at 6\u201312 months of life.",
            "startOffset": 32519,
            "title": "Results"
        },
        {
            "endOffset": 45170,
            "parents": [],
            "secId": "s0050",
            "sentence": "Another possible reason that efficacy may have been greater against first episodes relates to the role of biofilms.",
            "startOffset": 45055,
            "title": "Discussion"
        },
        {
            "endOffset": 31625,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The statistical analyses were performed using the Statistical Analysis System (SAS) in the SAS Drug Development environment.",
            "startOffset": 31501,
            "title": "Sample size and statistical analysis"
        },
        {
            "endOffset": 38498,
            "parents": [],
            "secId": "s0050",
            "sentence": "Anti-Ply antibody concentrations were frequently beyond the assay ULOQ following the booster dose.",
            "startOffset": 38400,
            "title": "Discussion"
        },
        {
            "endOffset": 25428,
            "parents": [],
            "secId": "s0010",
            "sentence": "Study product (vaccine or placebo) was administered intramuscularly into the right thigh (primary vaccination) or deltoid (booster vaccination).",
            "startOffset": 25284,
            "title": "Material and methods"
        }
    ],
    "docId": "S0264410X19313040",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "LHammitt@JHU.edu",
                "first": "Laura L.",
                "initial": "L.L.",
                "last": "Hammitt"
            },
            {
                "email": null,
                "first": "James C.",
                "initial": "J.C.",
                "last": "Campbell"
            },
            {
                "email": null,
                "first": "Dorota",
                "initial": "D.",
                "last": "Borys"
            },
            {
                "email": null,
                "first": "Robert C.",
                "initial": "R.C.",
                "last": "Weatherholtz"
            },
            {
                "email": null,
                "first": "Raymond",
                "initial": "R.",
                "last": "Reid"
            },
            {
                "email": null,
                "first": "Novalene",
                "initial": "N.",
                "last": "Goklish"
            },
            {
                "email": null,
                "first": "Lawrence H.",
                "initial": "L.H.",
                "last": "Moulton"
            },
            {
                "email": null,
                "first": "Magali",
                "initial": "M.",
                "last": "Traskine"
            },
            {
                "email": null,
                "first": "Yue",
                "initial": "Y.",
                "last": "Song"
            },
            {
                "email": null,
                "first": "Kristien",
                "initial": "K.",
                "last": "Swinnen"
            },
            {
                "email": null,
                "first": "Mathuram",
                "initial": "M.",
                "last": "Santosham"
            },
            {
                "email": null,
                "first": "Katherine L.",
                "initial": "K.L.",
                "last": "O'Brien"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.09.076",
        "firstpage": "7482",
        "issn": "0264410X",
        "keywords": [
            "Acute otitis media",
            "Immunogenicity",
            "Native American",
            "Reactogenicity",
            "Streptococcus pneumoniae",
            "Vaccines"
        ],
        "lastpage": "7492",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study"
    }
}